至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport.

EMBO J.. 2018; 
FregnoIlaria,FasanaElisa,BergmannTimothy J,RaimondiAndrea,LoiMarisa,SoldàTatiana,GalliCarmela,D'AntuonoRocco,MoroneDiego,DanieliAlberto,PaganettiPaolo,van AnkenEelco,MolinariMaur
Products/Services Used Details Operation
Plasmid DNA Preparation FAM134B-HA and FAM134BLIR-HA (DDFELL to AAAAAA) expression plasmids were purchased from GenScript. Get A Quote

摘要

Maintenance of cellular proteostasis relies on efficient clearance of defective gene products. For misfolded secretory proteins, this involves dislocation from the endoplasmic reticulum (ER) into the cytosol followed by proteasomal degradation. However, polypeptide aggregation prevents cytosolic dislocation and instead activates ill-defined lysosomal catabolic pathways. Here, we describe an ER-to-lysosome-associated degradation pathway (ERLAD) for proteasome-resistant polymers of alpha1-antitrypsin Z (ATZ). ERLAD involves the ER-chaperone calnexin (CNX) and the engagement of the LC3 lipidation machinery by the ER-resident ER-phagy receptor FAM134B, echoing the initiation of starvation-induced, recepto... More

关键词

ER‐phagy,ER‐to‐lysosome‐associated degradation,LC3 lipidation,endolysosomes,proteasome‐resistant aggreg